Mersana Therapeutics (MRSN)
(Delayed Data from NSDQ)
$2.12 USD
+0.08 (3.92%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $2.13 +0.01 (0.47%) 7:42 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Mersana Therapeutics, Inc. (MRSN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.33 | $9.00 | $3.00 | 210.29% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Mersana Therapeutics, Inc. comes to $6.33. The forecasts range from a low of $3.00 to a high of $9.00. The average price target represents an increase of 210.29% from the last closing price of $2.04.
Analyst Price Targets (9 )
Broker Rating
Mersana Therapeutics, Inc. currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 1.40 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, eight are Strong Buy, representing 80% of all recommendations. A month ago, Strong Buy represented 80%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.40 | 1.40 | 1.40 | 1.44 | 1.44 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/27/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/14/2024 | Robert W. Baird & Co. | Colleen M Kusy | Hold | Hold |
8/14/2024 | Truist Securities | Asthika S Goonewardene | Strong Buy | Strong Buy |
8/13/2024 | Wedbush Securities | David M Nierengarten | Strong Buy | Strong Buy |
8/13/2024 | Cowen & Co. | Tara Bancroft | Strong Buy | Strong Buy |
8/13/2024 | SVB Securities | Jonathan W Chang | Strong Buy | Strong Buy |
7/29/2024 | LifeSci Capital | Charles Zhu | Not Available | Strong Buy |
2/29/2024 | BTIG | Kaveri Pohlman | Hold | Strong Buy |
2/29/2024 | Guggenheim Securities | Michael Schmidt | Hold | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.40 |
ABR (Last week) | 1.40 |
# of Recs in ABR | 10 |
Average Target Price | $6.33 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 81 of 253 |
Current Quarter EPS Est: | -0.19 |
MRSN FAQs
Mersana Therapeutics, Inc. (MRSN) currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms.
The average price target for Mersana Therapeutics, Inc. (MRSN) is $6.33. The current on short-term price targets is based on 5 reports.
The forecasts for Mersana Therapeutics, Inc. (MRSN) range from a low of $3 to a high of $9. The average price target represents a increase of $210.29 from the last closing price of $2.04.
The current UPSIDE for Mersana Therapeutics, Inc. (MRSN) is 210.29%
Based on short-term price targets offered by nine analysts, the average price target for Mersana Therapeutics, Inc. comes to $6.33. The forecasts range from a low of $3.00 to a high of $9.00. The average price target represents an increase of 210.29% from the last closing price of $2.04.